Research & Development

Can GTB-3650 Revolutionize CD33+ Leukemia Treatment with NK Cell Engagers?
Research & Development Can GTB-3650 Revolutionize CD33+ Leukemia Treatment with NK Cell Engagers?

In a significant achievement for GT Biopharma, Inc., the FDA has granted clearance for the company's Investigational New Drug (IND) application for GTB-3650, a novel NK cell engager aimed at treating CD33+ leukemia. This regulatory milestone allows the clinical-stage immuno-oncology company to

Can Diverse Clinical Trials Restore Trust in Minority Communities?
Research & Development Can Diverse Clinical Trials Restore Trust in Minority Communities?

The healthcare system's history of unethical practices and ongoing issues has fostered a deep mistrust among minority communities. This mistrust affects everything from routine healthcare appointments to participation in clinical trials. Despite significant efforts to increase diversity,

Can Treg Therapy by PolTREG Revolutionize Type-1 Diabetes Treatment?
Research & Development Can Treg Therapy by PolTREG Revolutionize Type-1 Diabetes Treatment?

Recent clinical advancements by PolTREG, a pioneering Polish biotechnology company, have cast a hopeful light on the treatment of type-1 diabetes (T1D). The company's breakthrough Treg therapy, PTG-007, has shown great promise in fundamentally altering the management of this autoimmune

Can WVE-003 Reform Huntington’s Treatment With Biomarker Innovations?
Research & Development Can WVE-003 Reform Huntington’s Treatment With Biomarker Innovations?

Huntington’s disease, a genetic disorder that leads to the gradual death of nerve cells in the brain, has long challenged the medical and scientific communities. Traditional treatments have provided only limited symptom relief, pushing the quest for innovative therapies that can alter the disease’s

AI Revolutionizes Drug Discovery Amid Pharma R&D Integration Challenges
Research & Development AI Revolutionizes Drug Discovery Amid Pharma R&D Integration Challenges

Artificial Intelligence (AI) is poised to transform drug discovery, ushering in an era of unprecedented innovation in the pharmaceutical industry. The promise of developing numerous high-quality drug candidates quickly and cost-effectively is becoming a reality. However, this revolution also brings

Auxilius Raises $10M to Transform Clinical Trial Financial Management
Research & Development Auxilius Raises $10M to Transform Clinical Trial Financial Management

Auxilius, a company specializing in Clinical Trial Financial Management (CTFM) software for the biopharma industry, has recently raised $10 million in financing led by SignalFire. With an astounding 800% year-over-year growth in annual recurring revenue (ARR) for 2023, this upsurge underscores the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later